Shattuck Labs STTK
NASDAQ STTK
$6.79 -0.17 (-2.44%)
As of: Sep 4, 2026 · 3:59 PM EDT

Shattuck Labs (STTK) Cash from Investing Activities (2019 - 2026)

Shattuck Labs (STTK) posted quarterly Cash from Investing Activities of $23.8 million for Q1 2026, up 52.87% year-over-year from $15.6 million in Q1 2025, and up 19.24% quarter-over-quarter from $20.0 million in Q4 2025.

Analysis

Shattuck Labs (STTK) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has reported Cash from Investing Activities for 8 consecutive years, with $23.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 52.87% year-over-year to $23.8 million; the TTM figure through Mar 2026 stood at $361000.0 (down 99.11% YoY), while the FY2025 annual figure was -$7.9 million, up 7.33% from the prior year.
  • Cash from Investing Activities advanced to $23.8 million in Q1 2026 per STTK's latest filing, from $20.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $55.9 million in Q4 2023 and bottomed at -$43.5 million in Q3 2025.
  • Historically, Cash from Investing Activities has averaged $10.5 million across 5 years, with a median of $17.8 million in 2025.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities jumped 611.71% — and 2025, when it plunged 5196.83%.
  • Shattuck Labs' Cash from Investing Activities stood at $31.5 million in 2022, then soared by 77.52% to $55.9 million in 2023, then plunged by 44.5% to $31.0 million in 2024, then slumped by 35.48% to $20.0 million in 2025, then gained by 19.24% to $23.8 million in 2026.
  • Business Quant data shows STTK's Cash from Investing Activities at $23.8 million in Q1 2026, $20.0 million in Q4 2025, and -$43.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Shattuck Labs 885.09 Mn 885.09 Mn - -144.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -144.95 Mn
Mar 31, 2026 23.85 Mn
Dec 31, 2025 20.00 Mn
Sep 30, 2025 -43.49 Mn
Mar 31, 2025 15.60 Mn
Dec 31, 2024 31.00 Mn
Sep 30, 2024 -821,000.00
Jun 30, 2024 -5.41 Mn
Mar 31, 2024 -33.28 Mn
Dec 31, 2023 55.85 Mn
Sep 30, 2023 -14.55 Mn
Jun 30, 2023 24.43 Mn
Mar 31, 2023 45.13 Mn
Dec 31, 2022 31.46 Mn
Sep 30, 2022 29.93 Mn
Jun 30, 2022 3.43 Mn
Mar 31, 2022 -15.38 Mn
Dec 31, 2021 25.60 Mn
Sep 30, 2021 11.24 Mn
Jun 30, 2021 14.84 Mn